Advanced Biomed Inc. Common Stock (NASDAQ:ADVB) — Market Cap & Net Worth
Market Cap & Net Worth: Advanced Biomed Inc. Common Stock (ADVB)
Advanced Biomed Inc. Common Stock (NASDAQ:ADVB) has a market capitalization of $6.13 Million ($6.13 Million) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28178 globally and #5726 in its home market, demonstrating a 14.47% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Advanced Biomed Inc. Common Stock's stock price $4.51 by its total outstanding shares 1652133 (1.65 Million). Review Advanced Biomed Inc. Common Stock (ADVB) financial obligations to assess the company's total debt and financial obligations.
Advanced Biomed Inc. Common Stock Market Cap History: 2025 to 2026
Advanced Biomed Inc. Common Stock's market capitalization history from 2025 to 2026. Data shows growth from $482.09K to $7.45 Million (0.00% CAGR).
Index Memberships
Advanced Biomed Inc. Common Stock is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.43 Trillion | 0.00% | #820 of 976 |
Weight: Advanced Biomed Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Advanced Biomed Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Advanced Biomed Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ADVB by Market Capitalization
Companies near Advanced Biomed Inc. Common Stock in the global market cap rankings as of June 17, 2026.
Key companies related to Advanced Biomed Inc. Common Stock by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.57 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #182 globally with a market cap of $128.10 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #626 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #663 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.57 Billion | $472.63 |
| #182 | Danaher Corporation | NYSE:DHR | $128.10 Billion | $181.35 |
| #626 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $573.00 |
| #663 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Advanced Biomed Inc. Common Stock Historical Marketcap From 2025 to 2026
Between 2025 and today, Advanced Biomed Inc. Common Stock's market cap moved from $482.09K to $ 7.45 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $7.45 Million | +1445.58% |
| 2025 | $482.09K | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Advanced Biomed Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.13 Million USD |
| MoneyControl | $6.13 Million USD |
| MarketWatch | $6.13 Million USD |
| marketcap.company | $6.13 Million USD |
| Reuters | $6.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Advanced Biomed Inc. Common Stock
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagul… Read more